Bluejay Diagnostics, Inc. (BJDX) Return on equity
Bluejay Diagnostics, Inc. (BJDX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-86.2%FY2023
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -86.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BJDX financial trends
BJDX RevenueBJDX Net incomeBJDX Net marginBJDX Gross profitBJDX Gross marginBJDX Operating incomeBJDX Operating marginBJDX Operating cash flowBJDX Free cash flowBJDX Capital expendituresBJDX Stock buybacksBJDX Dividends paidBJDX Total assetsBJDX Total liabilitiesBJDX Shareholders’ equityBJDX overview →